gusperimus has been researched along with Multiple Sclerosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernasconi, L; Brunnschweiler, H; Gehlen, W; Haas, J; Hartard, C; Hartung, HP; Kappos, L; Lagreze, HL; Radü, EW; Rüttinger, H | 1 |
Grasela, DM; Kelley, SL; Nadler, SG; Ramos, EL | 1 |
Hartung, HP; Kappos, L; Theobald, K | 1 |
Schorlemmer, HU; Seiler, FR | 2 |
2 review(s) available for gusperimus and Multiple Sclerosis
Article | Year |
---|---|
Deoxyspergualin: mechanism of action and pharmacokinetics.
Topics: Animals; Antibody Formation; Arthritis, Rheumatoid; Cell Nucleus; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Models, Biological; Multiple Sclerosis; Neoplasms; NF-kappa B; T-Lymphocytes | 1996 |
[15+/-deoxyspergualin, hope for patients with multiple sclerosis?].
Topics: Animals; B-Lymphocytes; Guanidines; Humans; Immunosuppressive Agents; Multiple Sclerosis; T-Lymphocytes | 1992 |
1 trial(s) available for gusperimus and Multiple Sclerosis
Article | Year |
---|---|
Treatment of multiple sclerosis with 15 +/- deoxyspergualin. Design of a controlled study with close MRI-monitoring.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Guanidines; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prospective Studies | 1993 |
2 other study(ies) available for gusperimus and Multiple Sclerosis
Article | Year |
---|---|
15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE).
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Guanidines; Immunosuppressive Agents; Multiple Sclerosis; Rats; Recurrence | 1991 |
Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Guanidines; Immunosuppressive Agents; Multiple Sclerosis; Rats; Rats, Inbred Lew; Recurrence | 1991 |